Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Wang, Feifei ^a   Yasuhara, Takao ^a   Shingo, Tetsuro ^a   Kameda, Masahiro ^a   Tajiri, Naoki ^a   Yuan, Wen J ^a   Kondo, Akihiko ^a   Kadota, Tomohito ^a   Baba, Tanefumi ^a   Tayra, Judith T ^a   Kikuchi, Yoichiro ^a   Miyoshi, Yasuyuki ^a   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GREEN FLUORESCENT PROTEIN; OXIDOPAMINE; STROMAL CELL DERIVED FACTOR 1ALPHA; TYROSINE 3 MONOOXYGENASE; AMPHETAMINE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; NEUROTOXIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; EXPERIMENTAL TEST; FEMALE; FIBROBLAST; IMMUNOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA; ANIMAL; BIOSYNTHESIS; CELL PROTECTION; CELL STRAIN; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GRAFT SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; NERVE CELL; PARKINSONISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

AMPHETAMINE; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CXCL12; CORPUS STRIATUM; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; GRAFT SURVIVAL; INFUSIONS, INTRAVENOUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MOTOR ACTIVITY; NEURONS; NEUROTOXINS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 77951248824     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-52     Document Type: Article

References (41)

1. Hornykiewicz O. Parkinson's disease: from brain homogenate to treatment. Fed Proc 1973, 32(2):183-90.
2. Treciokas LJ, Ansel RD, Markham CH. One to two year treatment of Parkinson's disease with levodopa. Calif Med 1971, 114(5):7-14. 1501971, 5087881.
3. Péchadre JC, Larochelle L, Poirier LJ. Parkinsonian akinesia, rigidity and tremor in the monkey. Histopathological and neuropharmacological study. J Neurol Sci 1976, 28(2):147-57. 10.1016/0022-510X(76)90100-3, 818342.
4. Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Am Neurol Assoc 1968, 93:56-63.
5. Cotzias GC. L-Dopa for Parkinsonism. N Engl J Med 1968, 278(11):630.
6. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994, 117(4):877-97. 10.1093/brain/117.4.877, 7922472.
7. Isacson O, Costantini L, Schumacher JM, Cicchetti F, Chung S, Kim K. Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells. Parkinsonism Relat Disord 2001, 7(3):205-212. 10.1016/S1353-8020(00)00059-6, 11331188.
8. Yang M, Donaldson AE, Jiang Y, Iacovitti L. Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells. Cell Mol Neurobiol 2003, 23(4-5):851-64. 10.1023/A:1025017423102, 1949421, 14514036.
9. Muraoka K, Shingo T, Yasuhara T, Kameda M, Yuen WJ, Uozumi T, Matsui T, Miyoshi Y, Date I. Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease. J Neurosurg 2008, 108(1):149-59. 10.3171/JNS/2008/108/01/0149, 18173325.
10. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990, 247(4942):574-7. 10.1126/science.2105529, 2105529.
11. Clarkson ED. Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results. Drugs Aging 2001, 18(10):773-85. 10.2165/00002512-200118100-00006, 11735624.
12. Bjorklund LM, Sánchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002, 99(4):2344-9. 10.1073/pnas.022438099, 122367, 11782534.
13. Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, Jiang CC. Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 2003, 21(2):190-9. 10.1634/stemcells.21-2-190, 12634415.
14. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418(6893):41-9. 10.1038/nature00870, 12077603.
15. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, Horuk R, Ali H, Snyderman R. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 1997, 272(45):28726-31. 10.1074/jbc.272.45.28726, 9353342.
16. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007, 21(12):3197-207. 10.1096/fj.06-6558com, 17496162.
17. Bonavia R, Bajetto A, Barbero S, Pirani P, Florio T, Schettini G. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett 2003, 139(2-3):181-9. 10.1016/S0378-4274(02)00432-0, 12628753.
18. Skrzydelski D, Guyon A, Daugé V, Rovère C, Apartis E, Kitabgi P, Nahon JL, Rostène W, Parsadaniantz SM. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem 2007, 102(4):1175-83. 10.1111/j.1471-4159.2007.04639.x, 17509088.
19. Khan MZ, Brandimarti R, Shimizu S, Nicolai J, Crowe E, Meucci O. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ 2008, 10:1663-72.
20. Shyu WC, Lin SZ, Yen PS, Su CY, Chen DC, Wang HJ, Li H. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther 2008, 324(2):834-49. 10.1124/jpet.107.127746, 18029549.
21. Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int 2008, 52(7):1332-42. 10.1016/j.neuint.2008.02.003, 18372079.
22. Sadan O, Bahat-Stromza M, Barhum Y, Levy YS, Pisnevsky A, Peretz H, Ilan AB, Bulvik S, Shemesh N, Krepel D, Cohen Y, Melamed E, Offen D. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev 2009, 18(8):1179-90. 10.1089/scd.2008.0411, 19243240.
23. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009, 57(1):13-23. 10.1002/glia.20731, 18661552.
24. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 2008, 10(4):340-52. 10.1080/14653240802021330, 18574767.
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-7. 10.1126/science.284.5411.143, 10102814.
26. Kotobuki N, Hirose M, Takakura Y, Ohgushi H. Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004, 28(1):33-9. 10.1111/j.1525-1594.2004.07320.x, 14720286.
27. Hovakimyan M, Haas SJ, Schmitt O, Gerber B, Wree A, Andressen C. Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour. J Anat 2006, 209(6):721-32. 10.1111/j.1469-7580.2006.00654.x, 2049002, 17118060.
28. Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, Yasuhara T, Maruo T, Tsuboi T, Uozumi T, Matsui T, Miyoshi Y, Hamada H, Date I. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci 2007, 26(6):1462-78. 10.1111/j.1460-9568.2007.05776.x, 17880388.
29. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G. Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 2001, 77(5):1226-36. 10.1046/j.1471-4159.2001.00350.x, 11389173.
30. Zheng H, Dai T, Zhou B, Zhu J, Huang H, Wang M, Fu G. SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis 2008, 201(1):36-42. 10.1016/j.atherosclerosis.2008.02.011, 18384792.
31. Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 2004, 18(10):1162-4.
32. Sredni B, Geffen-Aricha R, Duan W, Albeck M, Shalit F, Lander HM, Kinor N, Sagi O, Albeck A, Yosef S, Brodsky M, Sredni-Kenigsbuch D, Sonino T, Longo DL, Mattson MP, Yadid G. Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models. FASEB J 2007, 21(8):1870-83. 10.1096/fj.06-7500com, 17314138.
33. Guyon A, Skrzydelsi D, Rovère C, Rostène W, Parsadaniantz SM, Nahon JL. Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J Neurochem 2006, 96(6):1540-50. 10.1111/j.1471-4159.2006.03659.x, 16476083.
34. Geeraerts T, Deiva K, M'sika I, Salim H, Héry C, Tardieu M. Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Neurosci Lett 2006, 399(1-2):115-20. 10.1016/j.neulet.2006.01.033, 16481105.
35. Phinney DG, Baddoo M, Dutreil M, Gaupp D, Lai WT, Isakova IA. Murine mesenchymal stem cells transplanted to the central nervous system of neonatal versus adult mice exhibit distinct engraftment kinetics and express receptors that guide neuronal cell migration. Stem Cells Dev 2006, 15(3):437-47. 10.1089/scd.2006.15.437, 16846379.
36. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci 2009, 16(1):12-20. 10.1016/j.jocn.2008.05.006, 19017556.
37. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003, 73(6):778-86. 10.1002/jnr.10691, 12949903.
38. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008, 10:233-48.
39. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, Lu M, Raginski K, Vanguri P, Smith A, Chopp M. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007, 27(1):6-13. 10.1038/sj.jcbfm.9600311, 16596121.
40. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004, 9(2):189-97. 10.1016/j.ymthe.2003.10.012, 14759803.
41. Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci 2006, 26(48):12497-511. 10.1523/JNEUROSCI.3719-06.2006, 17135412.